Enhanced tumor necrosis factor-α production following endotoxin challenge in rats is an early event during magnesium deficiency

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1453, Issue 1, 1999, Pages 35-40

  Malpuech Brugère, Corinne ^b   Nowacki, Wojciech ^a,b   Rock, Edmond ^b   Gueux, Elyett ^b   Mazur, Andrzej ^b   Rayssiguier, Yves ^b  

^a WROC AW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

^b Centre de Recherché en Nutrition Humaine d'Auvergne CRNH   (France)

Author keywords

Endotoxin; Magnesium; Rat; Tumor necrosis factor

Indexed keywords

ENDOTOXIN; MAGNESIUM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET; INFLAMMATION; MAGNESIUM DEFICIENCY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPTIC SHOCK;

ANIMALS; ENDOTOXINS; MAGNESIUM; MAGNESIUM DEFICIENCY; MALE; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032928873     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4439(98)00081-7     Document Type: Article

References (35)

1. M.E. Shils, Magnesium, in: M.E. Shils, J.A. Olson, M. Shike (Eds.), Modern Nutrition in Health and Disease, vol. 1, Lea and Febiger, Malvern, 1994, ch. 8, pp. 164-184.
2. J. Durlach, in: J. Durlach (Ed.), Magnesium in Clinical Practice, John Libbey and Co., London, 1988.
3. H.D. Kruse, E.R. Orent, E.V. McCollum, Studies on magnesium deficiency in animals. I. Symptomatology resulting from magnesium deprivation, J. Biol. Chem. 96 (1932) 519-539.
4. Y. Rayssiguier, C. Malpuech, W. Nowacki, E. Rock, E. Gueux, A. Mazur, Inflammatory response in magnesium deficiency, in: R. Smetana (Ed.), Advances in Magnesium Research. 1. Magnesium in Cardiology, John Libbey and Co., London, 1995, pp. 415-416.
5. W.B. Weglicki, T.M. Phillips, Pathobiology of magnesium deficiency: a cytokine/neurogenic inflammation hypothesis, Am. J. Physiol. 263 (1992) R734-R737.
6. T. Günther, J. Vormann, V. Höllriegl, Lipid peroxidation and magnesium deficiency, in: M.J. Halpern (Ed.), Current Research in Magnesium, John Libbey and Co., London, 1996, pp. 189-193.
7. Y. Rayssiguier, E. Gueux, L. Bussière, J. Durlach, A. Mazur, Dietary magnesium affects susceptibility of lipoproteins and tissues to peroxidation in rats, J. Am. Coll. Nutr. 12 (1993) 133-137.
8. E. Rock, C. Astier, C. Lab, X. Vignon, E. Gueux, C. Motta, Y. Rayssiguier, Dietary magnesium deficiency in rats enhances free radical production in skeletal muscle, J. Nutr. 125 (1995) 1205-1210.
9. C. Astier, E. Rock, C. Lab, E. Gueux, A. Mazur, Y. Rayssiguier, Functional alterations in sarcoplasmic reticulum membranes of magnesium-deficient rat skeletal muscle as consequences of free radical mediated process, Free Radic. Biol. Med. 20 (1996) 667-674.
10. A.M. Freedman, A.H. Atrakchi, M.M. Cassidy, R.A. Muesing, W.B. Weglicki, Magnesium deficiency-induced cardiomyopathy: protection by vitamin E, Biochem. Biophys. Res. Commun. 170 (1990) 1102-1106.
11. M. Salem, N. Kasinski, R. Munoz, B. Chernow, Progressive magnesium deficiency increases mortality from endotoxin challenge : protective effects of acute magnesium replacement therapy, Crit. Care Med. 23 (1995) 108-118.
12. M.A. Freudenberg, D. Keppler, C. Galanos, Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensibilization to endotoxin, Infect. Immun. 51 (1986) 891-895.
13. B. Beutler, A. Cerami, Cachectin/tumor necrosis factor: an endogenous mediator of shock and inflammation, Annu. Rev. Biochem. 57 (1988) 505-516.
14. B. Beutler, I.W. Milsark, A. Cerami, Passive immunization against cachectin/tumor necrosis factor (TNF) protects mice from the lethal effect of endotoxin, Science 229 (1985) 869-871.
15. M.A. Freudenberg, C. Galanos, Tumor necrosis factor alpha mediates lethal activity of killed Gram-negative and Gram-positive bacteria in D-galactosamine-treated mice, Infect. Immun. 59 (1991) 2110-2115.
16. C. Malpuech-Brugère, J. Kuryszko, W. Nowacki, E. Rock, Y. Rayssiguier, A. Mazur, Early morphological and immunological alterations in the spleen during magnesium deficiency in the rat, Magnes. Res. (1998) in press.
17. L. Givalois, J. Dornand, M. Mekaouche, M.D. Solier, A.F. Bristow, G. Ixart, P. Siaud, I. Assenmacher, G. Barbanel, Temporal cascade of plasma level surges in ACTH, corticosterone, and cytokines in endotoxin-challenged rats, Am. J. Physiol. 276 (1994) R164-R170.
18. P. Bois, A. Gascon, A. Beaulnes, Histamine-liberating effect of magnesium deficiency in the rat, Nature 197 (1963) 501-502.
19. T. Günther, K. Schümann, J. Vormann, Tumor necrosis factor-a, prostanoids and immunoglobulins in magnesium deficiency, Magnes. Bull. 17 (1995) 109-114.
20. J.A.M. Maier, C. Malpuech-Brugère, E. Rock, Y. Rayssiguier, A. Mazur, Serum from magnesium-deficient rats affects vascular endothelial cells in culture : role of hyperlipemia and inflammation, J. Nutr. Biochem. 9 (1998) 17-22.
21. E. Rock, C. Astier, C. Lab, C. Malpuech, W. Nowacki, E. Gueux, A. Mazur, Y. Rayssiguier, Magnesium deficiency in rats induces a rise in plasma nitric oxide level, Magnes. Res. 8 (1995) 237-242.
22. W.B. Weglicki, I.T. Mak, J.H. Kramer, B.F. Dickens, M.M. Cassidy, R.E. Stafford, T.M. Phillips, Role of free radicals and substance P in magnesium deficiency, Cardiovasc. Res. 31 (1996) 677-682.
23. J.S. Downey, J. Han, Cellular activation mechanisms in septic shock, Front. Biosci. 3 (1998) D468-D476.
24. S. Bahrami, H. Redl, G. Schlag, Models of endotoxemia in rodents, in: G. Schlag, H. Redl (Eds.), Pathophysiology of Shock, Sepsis, and Organ Failure, Springer-Verlag, Berlin, 1993, pp. 1019-1030.
25. H. Redl, G. Schlag, S. Bahrami, J. Davies, A. Waage, M. Ceska, W.A. Buurman, G. Adolf, The cytokine network in trauma and sepsis. I. TNF and IL-8, in: G. Schlag, H. Redl (Eds.), Pathophysiology of Shock, Sepsis, and Organ Failure, Springer-Verlag, Berlin, 1993, pp. 468-490.
26. L. Martindale, F.W. Heaton, Magnesium deficiency in the adult rat, Biochem. J. 92 (1994) 119-126.
27. L.T. Iseri, J.H. French, Magnesium: nature's physiologic calcium blocker, Am. Heart J. 108 (1984) 188-193.
28. R.S. Hotchkiss, W.N. Bowling, I.E. Karl, D.F. Osborne, M.W. Flye, Calcium antagonists inhibit oxidative burst and nitrite formation in lipopolysaccharide-stimulated rat peritoneal macrophages, Shock 8 (1997) 170-178.
29. G. Schlag, H. Redl (Eds.), Pathophysiology of Shock, Sepsis, and Organ Failure, Springer-Verlag, Berlin, 1993.
30. R.K. Rude, Magnesium homeostasis, in: M. Bilezikian (Ed.), Principles of Bone Biology, Academic Press, London, 1996, pp. 277-293.
31. R.C. Bone, C.J. Fisher, T.P. Clemmer, C.J. Slotman, C.A. Metz, R.A. Balk, Sepsis syndrome: a valid clinical entity, Crit. Care Med. 171 (1989) 389-393.
32. T. Calandra, J. Baumgartner G.E. Grau, M. Wu, P. Lambert, J. Schellekens, J. Verhoef, M.P. Glauser, Swiss-Dutch J5. Immunoglobulin Study Group, Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-α, and interferon-γ in the serum of patients with septic shock, J. Infect. Dis. 161 (1990) 982-987.
33. J.M. Debets, H.R. Kampmeijer, P.M.H. van der Linden, W.A. Buurman, C.J. van der Linden, Plasma tumor necrosis factor and mortality in critically ill septic patients, Crit. Care Med. 17 (1989) 489-494.
34. A. Waage, A. Halstensen, T. Espevik, An association between tumor necrosis factor and serum and fatal outcome in patients with meningococcal disease, Lancet 14 (1987) 355-357.
35. A. Waage, P. Brandtzaeg, A. Halstelsen, P. Kierulf, T. Espevik, The complex pattern of cytokines in serum from patients with meningococcal septic shock, J. Exp. Med. 169 (1989) 333-338.